R&D Partner Content The Obesity Drug Development Summit has landed in Europe! The Obesity Drug Development Summit Europe is your perfect platform to be in a prime position to be at the forefront of this movement.
R&D Partner Content 8th Neuropsychiatric Drug Development Summit The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum, capturing advancements across discovery...
R&D Partner Content 7th TRP Europe | November 2025, Amsterdam | Agenda Released With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, real momentum is building in the field.
Market Access Partner Content 13th IMPACCT Real-World Evidence Summit Recognized as the industry’s most established and trusted event for real-world evidence and evidence generation professionals
R&D Partner Content 16th World ADC San Diego 2025 The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Market Access Partner Content EVERSANA expands commercialisation portfolio with OS Therapi... EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic partnerships to support the US commercialisation of innovative therapies from O
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.